Gilja, Odd Helge

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study

El-Salhy, M., Hatlebakk, J. G., Gilja, O. H., Bråthen Kristoffersen, A., & Hausken, T. (2020) · Gut

Gastrointestinal motility and disordersGut microbiota and health

Cited by 498

EFSUMB Recommendations and clinical guidelines for Intestinal Ultrasound (GIUS) in inflammatory bowel diseases

Maconi, G., Nylund, K., Ripolles, T., Calabrese, E., Dirks, K., Dietrich, C., Hollerweger, A., Sporea, I., Saftoiu, A., Maaser, C., et al. (2018) · Ultraschall in der Medizin - European Journal of Ultrasound

Inflammatory Bowel DiseaseUltrasound in Clinical Applications

Cited by 232

Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis

Vesterhus, M., Hov, J. R., Holm, A., Schrumpf, E., Nygård, S., Godang, K., Andersen, I. M., Næss, S., Thorburn, D., Saffioti, F., et al. (2015) · Hepatology

Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment

Cited by 138

The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation

Mazzawi, T., Lied, G. A., Sangnes, D. A., El-Salhy, M., Hov, J. R., Gilja, O. H., Hatlebakk, J. G., & Hausken, T. (2018) · PLoS ONE

Gastrointestinal motility and disordersGut microbiota and health

Cited by 92

Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study

de Vries, E. M. G., Färkkilä, M., Milkiewicz, P., Hov, J. R., Eksteen, B., Thorburn, D., Chazouillères, O., Pares, A., Nygård, S., Gilja, O. H., et al. (2017) · Liver International

Liver Diseases and ImmunityLiver Disease Diagnosis and Treatment

Cited by 83